Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for AVTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 5.630B
March 31, 2026 5.589B
December 31, 2025 5.565B
September 30, 2025 5.570B
June 30, 2025 6.286B
March 31, 2025 6.098B
December 31, 2024 5.957B
September 30, 2024 5.553B
June 30, 2024 5.435B
March 31, 2024 5.336B
December 31, 2023 5.253B
September 30, 2023 5.099B
June 30, 2023 5.011B
March 31, 2023 4.995B
December 31, 2022 4.855B
September 30, 2022 4.591B
June 30, 2022 4.470B
March 31, 2022 4.358B
Date Value
December 31, 2021 4.197B
September 30, 2021 4.105B
June 30, 2021 2.986B
March 31, 2021 2.806B
December 31, 2020 2.674B
September 30, 2020 2.552B
June 30, 2020 2.541B
March 31, 2020 2.440B
December 31, 2019 2.462B
September 30, 2019 2.356B
June 30, 2019 2.411B
March 31, 2019 792.70M
December 31, 2018 807.60M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 969.60M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Medpace Holdings, Inc. 433.86M
Champions Oncology, Inc. 3.939M
Personalis, Inc. 235.16M
Adaptive Biotechnologies Corp. 142.91M
10X Genomics, Inc. 825.55M

Shareholders Equity (Quarterly) Related Metrics